Location History:
- Pune, IN (2014)
- Hinjewadi, IN (2015)
Company Filing History:
Years Active: 2014-2015
Title: The Innovative Contributions of Inventor Yogesh Shejul
Introduction
Yogesh Shejul, an inventive mind located in Hinjewadi, India, has made significant strides in the field of pharmaceuticals. With a focus on adenosine receptor antagonists, he holds two patents that address critical health conditions, showcasing his commitment to medical advancement and research.
Latest Patents
Yogesh's latest patents focus on two groundbreaking areas. The first patent, titled "Fused Tricyclic Compounds as Adenosine Receptor Antagonists," discloses novel fused tricyclic compounds useful for treating various diseases and disorders linked to the A2A adenosine receptor. These include Parkinson's disease, Alzheimer's disease, neurodegenerative disorders, and an array of other health issues. The patent outlines methods for preparing these compounds and emphasizes their therapeutic potential.
The second patent, "Substituted Fused Pyrimidine Compounds, Its Preparation and Uses Thereof," introduces substituted fused pyrimidine compounds that also target adenosine receptor activity. This patent not only details the compounds but also provides processes for their preparation, further contributing to treatment strategies for conditions affected by adenosine receptor activity.
Career Highlights
Yogesh Shejul is currently associated with Advinus Therapeutics Private Limited, where he applies his expertise in drug development and innovation. His work has been pivotal in addressing pressing medical needs, establishing him as an influential figure in pharmaceutical research.
Collaborations
In his professional journey, Yogesh has had the privilege of collaborating with talented colleagues such as Vidya Ramdas and Sujay Basu. Together, they have contributed to research that aims to enhance patient outcomes through novel therapeutic strategies and drug development.
Conclusion
Yogesh Shejul's contributions to the field of pharmaceuticals reflect a deep commitment to advancing medical science. With his innovative work in adenosine receptor antagonists and ongoing collaborations, he continues to pave the way for new treatments that could significantly improve the quality of life for many individuals facing debilitating conditions. His patents not only exemplify technical ingenuity but also highlight the importance of innovation in addressing global health challenges.